In our opinion, this feature of FGF10 would not hamper its therapeutic value in stroke because the time window for stroke treatment is 3.5–4 hours1 and the intracellular signaling cascade triggered by a bolus FGF10 treatment could still exert biological functions in this period. Here, FGF10 is linked to stroke disorder.